Author

György Rokszin

Observed names: G. Rokszin, GYÖRGY ROKSZIN, Gyorgy Rokszin, Rokszin G, Rokszin, György, Rokszin, György Aurél, Rokszin,GyÃ¶rgy

Observed institutions: Semmelweis University, Magyar Agrár- és Élettudományi Egyetem, Asklepios, University of Veterinary Medicine, Békés Megyei Központi Kórház, Hungarian Academy of Sciences, University of Pecs

ORCID: 0009-0002-0568-001X

Observed ORCID: 0009-0002-0568-001X

OpenAlex ID: A5048348589

Effectiveness and Waning of Protection With Different SARS-CoV-2 Primary and Booster Vaccines During the Delta Pandemic Wave in 2021 in Hungary (HUN-VE 3 Study)

2022 · Zoltán Vokó, Zoltán Kiss, et al. · Frontiers in Immunology · 44

PDF

Revising Incidence and Mortality of Lung Cancer in Central Europe: An Epidemiology Review From Hungary

2019 · Krisztina Bogos, Zoltán Kiss, et al. · Frontiers in Oncology · 36

PDF

Changes in the incidence and prevalence of type 1 and type 2 diabetes among 2 million children and adolescents in Hungary between 2001 and 2016 – a nationwide population-based study

2019 · László Barkai, Zoltán Kiss, et al. · Archives of Medical Science · 36

PDF

Persistence of initial oral antidiabetic treatment in patients with type 2 diabetes mellitus

2012 · György Jermendy, István Wittmann, et al. · Medical Science Monitor · 32

PDF

Different Trends in Excess Mortality in a Central European Country Compared to Main European Regions in the Year of the COVID-19 Pandemic (2020): a Hungarian Analysis

2021 · Krisztina Bogos, Zoltan Kiss, et al. · Pathology & Oncology Research · 31

PDF

Risk of morbidity and mortality in patients with type 2 diabetes treated with sodium-glucose cotransporter-2 inhibitor and/or dipeptidyl peptidase-4 inhibitor: a nationwide study

2021 · Gábor Sütő, Gergő A Molnár, et al. · BMJ Open Diabetes Research & Care · 29

PDF

Persistence to Treatment with Novel Antidiabetic Drugs (Dipeptidyl Peptidase-4 Inhibitors, Sodium-Glucose Co-Transporter-2 Inhibitors, and Glucagon-Like Peptide-1 Receptor Agonists) in People with Type 2 Diabetes: A Nationwide Cohort Study

2018 · György Jermendy, Zoltán Kiss, et al. · Diabetes Therapy · 28

PDF

Age and Gender Specific Lung Cancer Incidence and Mortality in Hungary: Trends from 2011 Through 2016

2021 · Lilla Tamási, Krisztian Horvath, et al. · Pathology & Oncology Research · 27

PDF

2018 · Zoltán Kiss, György Rokszin, et al. · Cardiovascular Diabetology · 26

PDF

Persistence with statin therapy in Hungary

2013 · Zoltan Kiss, Laszlo Nagy, et al. · Archives of Medical Science · 26

PDF

Sodium-Glucose Co-Transporter 2 Inhibitors May Change the Development of Urinary Tract and Hematological Malignancies as Compared With Dipeptidyl Peptidase-4 Inhibitors: Data of the Post-Hoc Analysis of a Nationwide Study

2021 · György Rokszin, Zoltán Kiss, et al. · Frontiers in Oncology · 24

PDF

Changing Trends in Melanoma Incidence and Decreasing Melanoma Mortality in Hungary Between 2011 and 2019: A Nationwide Epidemiological Study

2021 · Gabriella Liszkay, Zoltan Kiss, et al. · Frontiers in Oncology · 23

PDF

Decreasing incidence of pharmacologically treated Type 2 diabetes in Hungary from 2001 to 2016: A nationwide cohort study

2019 · György Jermendy, Zoltán Kiss, et al. · Diabetes Research and Clinical Practice · 19

Changing Patterns of Antihyperglycaemic Treatment among Patients with Type 2 Diabetes in Hungary between 2015 and 2020—Nationwide Data from a Register-Based Analysis

2022 · György Jermendy, Zoltán Kiss, et al. · Medicina · 17

PDF

Lung Cancer in Hungary

2020 · Krisztina Bogos, Zoltán Kiss, et al. · Journal of Thoracic Oncology · 17

PDF

A cukorbeteg-ellátás mutatóinak alakulása Magyarországon 2001–2014 között. Az Országos Egészségbiztosítási Pénztár adatbázis-elemzésének célja és módszertana

2016 · György Jermendy, Péter Kempler, et al. · Orvosi Hetilap · 17

Prognosis, Cost, and Occurrence of Colorectal, Lung, Breast, and Prostate Cancer in Hungary

2015 · András Inotai, Zsolt Abonyi-Tóth, et al. · Value in Health Regional Issues · 16

Young adult patients with type 1 diabetes have a higher risk of mortality than those of similar age with type 2 diabetes: A nationwide analysis in Hungary

2019 · Zoltán Kiss, György Rokszin, et al. · Diabetes/Metabolism Research and Reviews · 15

PDF

Improvement in breast cancer survival across molecular subtypes in Hungary between 2011 and 2020: a nationwide, retrospective study

2025 · Miklós Darida, Gábor Rubovszky, et al. · Frontiers in Oncology · 13

Effect of single-pill versus free equivalent combinations on persistence and major adverse cardiovascular events in hypertension: a real-world analysis

2024 · Gábor Simonyi, Michel Burnier, et al. · Journal of Hypertension · 13

Improvement in Lung Cancer Survival: 6-Year Trends of Overall Survival at Hungarian Patients Diagnosed in 2011–2016

2021 · Krisztina Bogos, Zoltan Kiss, et al. · Pathology & Oncology Research · 13

PDF

Changes in mortality rates and ratios in people with pharmacologically treated type 2 diabetes mellitus between 2001 and 2016 in Hungary

2020 · György Jermendy, Zoltán Kiss, et al. · Diabetes Research and Clinical Practice · 13

Effectiveness of SARS-CoV-2 primary vaccines and boosters in patients with type 2 diabetes mellitus in Hungary (HUN-VE 4 Study)

2024 · Gergő A Molnár, Zoltán Vokó, et al. · BMJ Open Diabetes Research & Care · 12

PDF

Morbidity and mortality of patients with diabetic neuropathy treated with pathogenetically oriented alpha-lipoic acid versus symptomatic pharmacotherapies – A nationwide database analysis from Hungary

2023 · György Jermendy, György Rokszin, et al. · Diabetes Research and Clinical Practice · 12

PDF

Interaction Between Statin Use, Coronary Artery Disease Phenotypes, on Computed Tomography Angiography, and Cardiovascular Outcomes

2025 · Bálint Szilveszter, Borbála Vattay, et al. · JACC. Cardiovascular imaging · 11

Works count: 109

Citation count: 738

H-index: 16

I10-index: 29